Standardization of Low Molecular Weight Heparins : A Collaborative Study

Summary A collaborative study was carried out, in which eight laboratories each assayed eight low molecular weight (LMW) heparins against the International Standard (IS) for heparin. APTT assays and three types of anti-Xa method were used. The results of this study showed that: 1. LMW heparins cannot be validly assayed against the IS by APTT or anti-Xa methods. 2. Potencies of LMW heparins vs. the IS differed considerably between the four types of assay method used and also between different laboratories using the same type of method. 3. Adoption of a single LMW heparin standard would improve validity, improve inter-laboratory variation, and largely abolish the differences between the three types of anti-Xa method. However, since calibration of a LMW heparin standard against the IS would give potencies that differ widely by the different assay methods, a single assay method such as the anti-Xa amidolytic, plasma, would need to be chosen for this calibration.

[1]  T. Barrowcliffe,et al.  A Collaborative Study Designed to Establish the 4th International Standard for Heparin , 1984, Thrombosis and Haemostasis.

[2]  J. Roussi,et al.  USE OF LOW-MOLECULAR-WEIGHT HEPARIN IN HEPARIN-INDUCED THROMBOCYTOPENIA WITH THROMBOTIC COMPLICATIONS , 1984, The Lancet.

[3]  H. Hemker,et al.  Determination of low molecular weight heparin in clinical laboratory. , 1984, Haemostasis.

[4]  M. Gent,et al.  The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits. , 1982, Blood.

[5]  T. Barrowcliffe,et al.  In vitro and in vivo studies of the anti-Xa activity of heparin. , 1981, Thrombosis research.

[6]  K. Kurachi,et al.  The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin. , 1981, The Biochemical journal.

[7]  U. Lindahl,et al.  Anticoagulant activities and effects on platelets of a heparin fragment with high affinity for antithrombin. , 1980, Thrombosis research.

[8]  R. Rosenberg,et al.  Effect of heparin and heparin fractions on platelet aggregation. , 1980, The Journal of clinical investigation.

[9]  T. Barrowcliffe,et al.  Anticoagulant Activities of High and Low Molecular Weight Heparin Fractions , 1979, British journal of haematology.

[10]  V. Kakkar,et al.  Anticoagulant activities of four unfractionated and fractionated heparins. , 1978, Thrombosis research.

[11]  T. Barrowcliffe,et al.  Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin iii and by gel filtration. , 1976, Thrombosis research.

[12]  T. Kirkwood,et al.  Four Heparin Preparations: Anti-Xa Potentiating Effect of Heparin after Subcutaneous Injection , 1976, Thrombosis and Haemostasis.

[13]  S. Wessler,et al.  Plasma heparin: a unique, practical, submicrogram-sensitive assay. , 1973, The Journal of laboratory and clinical medicine.

[14]  J. O. Irwin,et al.  Statistical Method in Biological Assay , 1953, Nature.